Drug interactions
Arformoterol + Potassium citrate
Severity: Minor
Arformoterol and Potassium citrate: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Arformoterol, a beta-2 agonist, can lower serum potassium by shifting potassium into cells, while potassium citrate supplies potassium. The effects offset rather than add, and the combination is generally not harmful.
What this interaction means in plain words
Arformoterol and Potassium citrate have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Arformoterol belongs to Respiratory; Potassium citrate belongs to Gastrointestinal Tract.
Why it happens
Opposing effects on serum potassium: intracellular shift by beta-2 agonism versus potassium supplementation.
What to do
Monitor serum potassium periodically, especially with high arformoterol doses or in patients at risk of hypokalemia or renal impairment.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Arformoterol and Potassium citrate, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Potassium citrate
Other interactions of Arformoterol
Frequently asked questions
Can I take Arformoterol with Potassium citrate?
MediHelp rates the interaction as minor. Arformoterol and Potassium citrate have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Arformoterol, a beta-2 agonist, can lower serum potassium by shifting potassium into cells, while potassium citrate supplies potassium. The effects offset rather than add, and the combination is generally not harmful.
How serious is the interaction between Arformoterol and Potassium citrate?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum potassium periodically, especially with high arformoterol doses or in patients at risk of hypokalemia or renal impairment.
What other medicines interact with Potassium citrate?
MediHelp also lists interactions of Potassium citrate with, for example, Triamterene, Amiloride, Amlodipine-benazepril. The full list is on the Potassium citrate page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
